EUVIMEDEUVIMED entdecken
Systematische Übersicht

Seizure outcomes after thalamic deep brain stimulation in drug‐resistant epilepsy: How electrode location, device platform, and epilepsy subtype drive response—A systematic review with pooled analysis

Margil Ranpariya iD, Gurleen Kaur, Amanda Schwandt, Ping Li, Osman Farooq, Alexus Ludwig, Imtiaz Nazam, Hussain Shallwani, Robert Glover

Epileptic Disorders · 2026-06 · 28 (3) · 661-677

DOI: 10.1002/epd2.70256 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Epileptic Disorders, online erschienen am 28.04.2026. Verfasst von Margil Ranpariya und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University at Buffalo, Buffalo, New York, USA. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Drug Resistant Epilepsy, Seizures, Thalamus. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Deep brain stimulation (DBS) targeting the anterior nucleus of the thalamus (ANT), centromedian nucleus (CM), and medial pulvinar nucleus (PuM) has emerged as a neuromodulatory intervention for adults with drug‐resistant epilepsy (DRE). Despite growing clinical experience, no pooled analysis has integrated outcomes across all three thalamic targets. A PRISMA‐compliant systematic search was conducted across PubMed, EMBASE, and Cochrane databases (January 2000–December 2025). Studies reporting seizure frequency reduction following thalamic DBS in ≥4 adults with DRE and ≥6 months of follow‐up were included. Pooled descriptive statistics and weighted mean analyses were calculated within each target separately; subgroup comparisons by seizure onset zone and epilepsy classification were performed within each nucleus. Nineteen studies (651 patients) met inclusion criteria: ten ANT ( n = 551), seven CM ( n = 89), and two PuM ( n = 11). Weighted mean seizure frequency reductions were 48.7% (ANT), 71.4% (CM), and 62.0% (PuM). Responder rates (≥50% reduction) were 48.7% (ANT), 76.2% (CM), and 60.0% (PuM). ANT DBS showed progressive improvement from year one (33%–41% reduction) through year five (56%–69% reduction). Temporal lobe origin predicted superior ANT outcomes. CM DBS was most effective for generalized epilepsy syndromes, including Lennox–Gastaut syndrome. PuM DBS yielded promising results for posterior quadrant and temporal‐plus epilepsy. Adverse events were target‐specific, including depression and memory impairment (ANT), postoperative drowsiness (CM), and hemorrhagic complications (PuM). No stimulation‐related mortality occurred. Thalamic DBS provides durable seizure reduction across three nuclear targets, with efficacy varying by epilepsy classification and seizure onset zone. ANT DBS has Class I evidence supporting its use in focal epilepsies, particularly temporal lobe origin. CM DBS shows strong preliminary efficacy for generalized epilepsies, warranting larger randomized trials. PuM DBS requires prospective validation. Head‐to‐head comparative trials are needed before individualized target selection recommendations can be made.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep Brain StimulationDrug Resistant EpilepsySeizuresThalamusHumansAnterior Thalamic NucleiTreatment Outcome

Stichwörter der Autor:innen

anterior thalamic nucleuscentromedian nucleusdeep brain stimulationdrug‐resistant epilepsyneuromodulationpulvinar nucleusseizure reductionsystematic review

Autor:innen und Institutionen

  • Department of Neurology, University at Buffalo, Buffalo, New York, USA.
  • Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA.
  • Department of Neurosurgery, University at Buffalo, Buffalo, New York, USA.

ORCID-Profile: Margil Ranpariya

Zitieren

APA

Ranpariya, M., Kaur, G., Schwandt, A., Li, P., Farooq, O., Ludwig, A., Nazam, I., Shallwani, H., & Glover, R. (2026). Seizure outcomes after thalamic deep brain stimulation in drug‐resistant epilepsy: How electrode location, device platform, and epilepsy subtype drive response—A systematic review with pooled analysis. Epileptic Disorders, 28(3), 661-677. https://doi.org/10.1002/epd2.70256

Vancouver

Ranpariya M, Kaur G, Schwandt A, Li P, Farooq O, Ludwig A, et al. Seizure outcomes after thalamic deep brain stimulation in drug‐resistant epilepsy: How electrode location, device platform, and epilepsy subtype drive response—A systematic review with pooled analysis. Epileptic Disorders. 2026;28(3):661-677. doi:10.1002/epd2.70256

BibTeX
@article{Ranpariya2026,
  author = {Ranpariya, Margil and Kaur, Gurleen and Schwandt, Amanda and Li, Ping and Farooq, Osman and Ludwig, Alexus and Nazam, Imtiaz and Shallwani, Hussain and Glover, Robert},
  title = {Seizure outcomes after thalamic deep brain stimulation in drug‐resistant epilepsy: How electrode location, device platform, and epilepsy subtype drive response—A systematic review with pooled analysis},
  journal = {Epileptic Disorders},
  year = {2026},
  volume = {28},
  number = {3},
  pages = {661--677},
  doi = {10.1002/epd2.70256}
}
Kostenlos starten →